Skip to search formSkip to main contentSkip to account menu

ivabradine

Known as: 3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one, Ivabradin, 7,8-dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Background and Purpose— Vascular effects of mental stress are only partially understood. Therefore, we studied effects of chronic… 
2010
2010
Aims. Migration of CD4-positive lymphocytes into the vessel wall is a critical step in atherogenesis. Recent data suggest that… 
2009
2009
PURPOSE To evaluate in mammalian rod photoreceptors the selectivity for hyperpolarization-activated cyclic nucleotide-gated (Hcn1… 
Review
2008
Review
2008
Neuropathic pain is induced by the injury to nervous systems and characterized by hyperalgesia, allodynia and spontaneous pain… 
2008
2008
Background: Tachycardia often facilitates ischemic ventricular fibrillation (VF). Objective: This study assessed the impact of… 
2008
2008
Aim of this retrospective analysis was to evaluate the effects of ivabradine given primarily as a heart rate-lowering agent on… 
Highly Cited
2004
Highly Cited
2004
Ivabradine selectively reduces heart rate (HR) by inhibiting the cardiac pacemaker If current, thus prolonging the duration of…